Interferon-gamma release assay testing to assess COVID-19 vaccination response in a SARS-CoV-2 seronegative patient on rituximab: a case report.

Ferguson, Jessica; Murugesan, Kanagavel; Banaei, Niaz; Liu, Anne

Ferguson, Jessica; Murugesan, Kanagavel; Banaei, Niaz; Liu, Anne.

Afiliação

Ferguson J; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA. Electronic address: jferg1@stanford.edu.
Murugesan K; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.
Banaei N; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA; Clinical Microbiology Laboratory, Stanford Health Care, Palo
Liu A; Division of Infectious Diseases and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California, USA; Division of Allergy, Immunology and Rheumatology, Department of Pediatrics, Stanford University School of Medicine, Stanford, California, USA.

Int J Infect Dis ; 110: 229-231, 2021 Sep.

Article em En | MEDLINE | ID: mdl-34216738

Assuntos

Vacinas contra COVID-19; COVID-19; Adulto; Anticorpos Antivirais; Feminino; Humanos; Testes de Liberação de Interferon-gama; Rituximab; SARS-CoV-2; Vacinação

Palavras-chave

Impaired humoral immunity; SARS-CoV-2; SARS-CoV-2 vaccination; T cell respone

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Adult / Female / Humans Idioma: En Revista: Int J Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google